NKCx Histopathological outcome* within 12 months after cervix cytology in 2022
641 Västerbotten

  Benign LSIL HSIL AIS Cancer Other PAD missing Total
Cytologi Number Percent Number Percent Number Percent Number Percent Number Percent Number Percent Number Percent Number Percent
Benign sample 493 6.8% 27 0.4% 10 0.1% . . 2 0.0% . . 6771 92.7% 7303 100.0%
ASCUS 236 38.6% 78 12.8% 26 4.3% . . . . . . 271 44.4% 611 100.0%
LSIL 184 30.4% 182 30.0% 57 9.4% 2 0.3% . . 1 0.2% 180 29.7% 606 100.0%
Atypical glandular cells/AGC 9 47.4% 2 10.5% 1 5.3% 4 21.1% . . . . 3 15.8% 19 100.0%
Unclear atypia 1 25.0% . . 3 75.0% . . . . . . . . 4 100.0%
ASC-H 30 24.6% 14 11.5% 68 55.7% 1 0.8% 2 1.6% 1 0.8% 6 4.9% 122 100.0%
HSIL 5 4.5% 4 3.6% 89 80.2% 2 1.8% 9 8.1% 1 0.9% 1 0.9% 111 100.0%
Suspected Adenocarcinom . . . . . . . . . . 1 50.0% 1 50.0% 2 100.0%
Adenocarcinoma . . . . . . . . . . . . 1 100.0% 1 100.0%
Squamous cell cancer . . . . . . . . 3 75.0% . . 1 25.0% 4 100.0%
Totalt 958 10.9% 307 3.5% 254 2.9% 9 0.1% 16 0.2% 4 0.0% 7235 82.4% 8783 100.0%

NOTE: Histopathological outcome from T83x taken into account.
This list includes only one diagnosis (the highest ranking) per person, applies to both Cyt and Pad.

* Harmonization of PAD codes classification between analysis registry and process registry has been carried out. PAD Class 0 (non diagnostic, unreasonable diagnosis) is excluded, and next PAD counts instead.
The classes 2a, b, c and 3a (suspected premalignant, pre-malignant UNS, HPV, suspected malignant) are grouped into 'Other'.
Process Registry's Class 1 (benign), 2d (LSIL) and 3b (manifest cancer) have all been introduced without exception. Some codes that occur beyond the scope of the process registry has been added to the different categories.
 

Snomed codes in the category
Cancer:
M80703, M83803, M83806